Castleview Partners, LLC

Position in PFE — Pfizer Inc

CIK 1737088 DALLAS, TX

Position in PFE

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$515,312

+$58,676 QoQ

Shares Held

21,400

+31.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.45%

of 13F equity value

Holder Rank

#1,737

of 2,821 holders

Holding Since

Jun 2021

17 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Castleview Partners, LLC holds $12,261,738 across 7 Drug Manufacturers - General names. PFE ranks #6 (4.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMY	Bristol Myers Squibb Co	83,526	$4,812,768
2	AMGN	Amgen Inc	10,552	$3,821,090
3	LLY	ELI LILLY & Co	909	$1,090,281
4	JNJ	Johnson & Johnson	4,044	$1,027,054
5	GILD	Gilead Sciences, Inc.	6,286	$794,173
6	PFE	Pfizer Inc This page	21,400	$515,312
7	ABBV	AbbVie Inc.	799	$201,060

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$515,312	21,400	+31.6%	Shares	Sole	2026-07-20
2026-03-31	$456,636	16,262	+20.5%	Shares	Sole	2026-05-01
2025-12-31	$336,025	13,495	+20.8%	Shares	Sole	2026-01-12
2025-09-30	$284,688	11,173	+20.4%	Shares	Sole	2025-10-10
2025-06-30	$224,874	9,277	+0.4%	Shares	Sole	2025-07-16
2025-03-31	$234,116	9,239	+15.2%	Shares	Sole	2025-04-22
2024-06-30	$224,315	8,017	+20.3%	Shares	Sole	2024-07-31
2024-03-31	$184,953	6,665	+36.6%	Shares	Sole	2024-05-10
2023-12-31	$140,466	4,879	+50.5%	Shares	Sole	2024-02-05
2023-09-30	$107,503	3,241	-61.9%	Shares	Sole	2023-10-26
2023-06-30	$312,073	8,508	-30.3%	Shares	Sole	2023-08-15
2023-03-31	$498,045	12,207	+2.4%	Shares	Sole	2023-05-16
2022-12-31	$610,780	11,920	-4.4%	Shares	Sole	2023-02-01
2022-09-30	$545,599	12,468	-23.5%	Shares	Sole	2022-11-10
2022-03-31	$844,213	16,307	-98.2%	Shares	Sole	2022-05-16
2021-12-31	$54,281,122	919,240	+5605.7%	Shares	Sole	2022-02-17
2021-06-30	$630,906	16,111	—	Shares	Sole	2021-08-17
No filing history on record for this holder in this stock.